Literature DB >> 13363909

Purification and properties of solubilized uricase.

P B HUDSON, M LONDON.   

Abstract

Entities:  

Keywords:  ENZYMES

Mesh：

Substances：

Year:  1956        PMID： 13363909     DOI： 10.1016/0006-3002(56)90010-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN： 0006-3002


× No keyword cloud information.
  9 in total

1.  Hormones and liver cytoplasm. 5. Enzymes concerned in nucleic-acid catabolism; as affected by hypophysectomy or adrenalectomy.

Authors:  E REID; B M STEVENS
Journal:  Biochem J       Date:  1958-02       Impact factor: 3.857

2.  Uricase and allantoinase in glyoxysomes.

Authors:  R R Theimer; H Beevers
Journal:  Plant Physiol       Date:  1971-02       Impact factor: 8.340

3.  Protective effect of polyanions on the constitutents of rat liver lysosomal fraction in acidic pH.

Authors:  W W Just; J O Leon-V; G Werner
Journal:  Histochemistry       Date:  1974

4.  [Inductive formation of particle-bound uricase in Hydrogenomonas H16 and other aerobic bacteria].

Authors:  H Kaltwasser
Journal:  Arch Mikrobiol       Date:  1968

5.  The hepatic effects of hypolipidemic drugs (clofibrate, nafenopin, tibric acid, and Wy-14,643) on hepatic peroxisomes and peroxisome-associated enzymes.

Authors:  D E Moody; J K Reddy
Journal:  Am J Pathol       Date:  1978-02       Impact factor: 4.307

6.  Increase in hepatic catalase and glycerol phosphate dehydrogenase activities on administration of clofibrate and clofenapate to the rat.

Authors:  T P Krishnakantha; C K Kurup
Journal:  Biochem J       Date:  1972-11       Impact factor: 3.857

7.  Microbodies in experimentally altered cells. IX. The fate of microbodies.

Authors:  D Svoboda; J Reddy
Journal:  Am J Pathol       Date:  1972-06       Impact factor: 4.307

8.  Microbodies in experimentally altered cells.

Authors:  D Svoboda; H Grady; D Azarnoff
Journal:  J Cell Biol       Date:  1967-10       Impact factor: 10.539

9.  Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout.

Authors:  Peter E Lipsky; Leonard H Calabrese; Arthur Kavanaugh; John S Sundy; David Wright; Marsha Wolfson; Michael A Becker
Journal:  Arthritis Res Ther       Date:  2014-03-04       Impact factor: 5.156
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.